In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on study results, an analyst ...
“Hyperthyroidism is often linked to Graves’ disease, another autoimmune condition that overstimulates the thyroid. Thyroid nodules, which are abnormal lumps in the thyroid, and excessive iodine can ...
A Cochrane review has concluded that antidepressants are more effective than placebo in reducing the symptoms of generalised anxiety disorder (GAD) in the short term.1 The National Institute for ...
The MM120 ODT Phase 3 clinical development program also includes the Voyage study for GAD and the Emerge study for major depressive disorder (MDD). The U.S. Food and Drug Administration has granted ...
Antidepressants, such as Prozac, are already used to treat the condition but Canadian and Italian scientists set out to analyse new evidence of the drugs' effectiveness.
Mind Medicine (MNMD) announced that the first patient has been dosed in Panorama, its second Phase 3 study evaluating MM120 ODT, a proprietary, ...
Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product ...
A new Cochrane review confirms that antidepressants effectively reduce symptoms of generalized anxiety disorder (GAD) under trial conditions, although there is limited data on long-term usage.
A new Cochrane review confirms that antidepressants effectively reduce symptoms of generalized anxiety disorder (GAD) under ...
Inc. stock despite strong Phase 2b data. Click for my updated look at MNMD stock and its market opportunities.
A study found that older adults with anxiety may have an increased risk of developing dementia—but this risk decreased once ...
If you have a history of depression or bipolar disorder, a healthy and active lifestyle is essential to minimizing the impact ...